Awareness and Practice Use of Folic Acid Prior Conception and in Early Pregnancy Among Pregnant Women Attending Nyamagana District Hospital Mwanza
Material type:
TextPublisher number: Wurzburg Road 35, BMC Premises, Post Code: 33102: P. O. Box 1464, Mwanza – Tanzania: Phone: +255 28 298 3384: Fax: +255 28 298 3386: Email: vc@bugando.ac.tz :www.bugando.ac.tzLanguage: English Language: Kiswahili Publication details: Mwanza, Tanzania: Catholic University of Health and Allied Sciences [CUHAS – Bugando] : ©2017Description: x; 31 Pages; Includes ReferencesSubject(s): Summary: Abstract:
Background: Preconception early pregnancy use of folic acid reduces occurrence of neural tube defect. Despite of the government effort to supply FA to prevent NTDs and anemia to pregnant women at ANC, it was not known if pregnant women were aware on the use of folic acid supplements.
Method used: The study was a cross-sectional descriptive study conducted in May 2017 and involved all pregnant women who are attending ANC at Nyamagana district hospital.
Results: This study enrolled 219 pregnant women, where by only 88 (40.18%) have ever used it and 131 (59.82%) have used It. The awareness on which disease can be prevented by use of folic acid, only 10.74% were aware that folic acid can prevent neural tube defect, 55.3% were aware that folic acid can prevent anemia while 10.74% were aware that folic acid can prevent both anemia and neural tube defect and 23.14% didn’t know exactly the disease which can prevented by preconception and early pregnancy use of folic acid.
Conclusion: The level of awareness and prevalence of use of folic acid preconception and in early pregnancy for prevention of neural tube defect is low among pregnant women attending Nyamagana district hospital.
| Item type | Current library | Collection | Status | Barcode | |
|---|---|---|---|---|---|
| UNDERGRADUATE DISSERTATIONS | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | NFIC | 1 | UD0124 |
Abstract:
Background: Preconception early pregnancy use of folic acid reduces occurrence of neural tube defect. Despite of the government effort to supply FA to prevent NTDs and anemia to pregnant women at ANC, it was not known if pregnant women were aware on the use of folic acid supplements.
Method used: The study was a cross-sectional descriptive study conducted in May 2017 and involved all pregnant women who are attending ANC at Nyamagana district hospital.
Results: This study enrolled 219 pregnant women, where by only 88 (40.18%) have ever used it and 131 (59.82%) have used It. The awareness on which disease can be prevented by use of folic acid, only 10.74% were aware that folic acid can prevent neural tube defect, 55.3% were aware that folic acid can prevent anemia while 10.74% were aware that folic acid can prevent both anemia and neural tube defect and 23.14% didn’t know exactly the disease which can prevented by preconception and early pregnancy use of folic acid.
Conclusion: The level of awareness and prevalence of use of folic acid preconception and in early pregnancy for prevention of neural tube defect is low among pregnant women attending Nyamagana district hospital.
There are no comments on this title.